Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ME2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA578057
Description
Positive Control: THP-1, HL-60 Predicted Reactivity: Rat (87%), Bovine (91%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
ME2 encodes a mitochondrial NAD-dependent malic enzyme, a homotetrameric protein, that catalyzes the oxidative decarboxylation of malate to pyruvate. It had previously been weakly linked to a syndrome known as Friedreich ataxia that has since been shown to be the result of mutation in a completely different gene. Certain single-nucleotide polymorphism haplotypes of this gene have been shown to increase the risk for idiopathic generalized epilepsy. Alternatively spliced transcript variants encoding different isoforms found for this gene.
Specifications
ME2 | |
Polyclonal | |
Unconjugated | |
Me2 | |
AW120568; D030040L20Rik; malate dehydrogenase; malate dehydrogenase (oxaloacetate-decarboxylating); malic enzyme 2; malic enzyme 2, NAD(+)-dependent, mitochondrial; Me2; NAD-dependent malic enzyme, mitochondrial; NAD-ME; ODS1; pyruvic-malic carboxylase | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
107029, 4200 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot | |
0.95 mg/mL | |
PBS with 20% glycerol and 0.025% ProClin 300; pH 7 | |
P23368, Q99KE1 | |
Me2 | |
Recombinant protein encompassing a sequence within the C-terminus region of human ME2. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction